Pharmaceutical Chemistry 1 - Practice

Daten

Offizielle Daten in der Fachveröffentlichung für das folgende akademische Jahr: 2025-2026

Lehrbeauftragte/r

Semesterwochenstunden

Vorlesungen: 0

Praktika: 42

Seminare: 0

Insgesamt: 42

Fachangaben

  • Kode des Kurses: OPG-R1G_23-T
  • 3 kredit
  • Pharmacy
  • Pharmaceutical Science and Pharmacy modul
  • autumn
Voraussetzungen:

OPA-P2E_23-T finished , OPA-S1E_23-T finished

Zahl der Kursteilnehmer für den Kurs:

min. 5 – max. 20

Thematik

Introduction to the quality control of substances used in pharmaceutical compounding. Pharmacopoeal analysis of selected inorganic substances.

Vorlesungen

Praktika

  • 6.

    Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.

    - Almási Attila
  • 5. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum. - Almási Attila
  • 2. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum. - Almási Attila
  • 3. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum. - Almási Attila
  • 4. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum. - Almási Attila
  • 1. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum. - Almási Attila
  • 7. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum. - Almási Attila
  • 8. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum. - Almási Attila
  • 9. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum. - Almási Attila
  • 10. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum. - Almási Attila
  • 11. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum. - Almási Attila
  • 12. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum. - Almási Attila
  • 13. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum. - Almási Attila
  • 14. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum. - Almási Attila
  • 15. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum. - Almási Attila
  • 16. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras. - Almási Attila
  • 17. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras. - Almási Attila
  • 18. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras. - Almási Attila
  • 19. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas. - Alizadeh Hussain
  • 20. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas. - Almási Attila
  • 21. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas. - Almási Attila
  • 22. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas. - Almási Attila
  • 23. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas. - Almási Attila
  • 24. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas. - Almási Attila
  • 25. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars). Silicon compounds. Magnesii trisilicas, Silica, colloidal hydrated - Almási Attila
  • 26. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars). Silicon compounds. Magnesii trisilicas, Silica, colloidal hydrated - Almási Attila
  • 27. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars). Silicon compounds. Magnesii trisilicas, Silica, colloidal hydrated - Almási Attila
  • 28. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Acidum boricum, Borax. - Almási Attila
  • 29. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Acidum boricum, Borax. - Almási Attila
  • 30. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Acidum boricum, Borax. - Almási Attila
  • 31. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas. - Almási Attila
  • 32. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas. - Almási Attila
  • 33. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas. - Almási Attila
  • 34. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP. - Almási Attila
  • 35. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP. - Almási Attila
  • 36. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP. - Almási Attila
  • 37. Classification of functional groups and heterocycles, their chemical properties (seminar). Quantification of potassium nitrate. - Almási Attila
  • 38. Classification of functional groups and heterocycles, their chemical properties (seminar). Quantification of potassium nitrate. - Almási Attila
  • 39. Classification of functional groups and heterocycles, their chemical properties (seminar). Quantification of potassium nitrate. - Almási Attila
  • 40. Introduction to sterochemistry. Relationships between structure, configuration and conformation using a molecule model. Spatial structure of morphine and morphine derivatives. - Almási Attila
  • 41. Introduction to sterochemistry. Relationships between structure, configuration and conformation using a molecule model. Spatial structure of morphine and morphine derivatives. - Almási Attila
  • 42. Introduction to sterochemistry. Relationships between structure, configuration and conformation using a molecule model. Spatial structure of morphine and morphine derivatives. - Almási Attila

Seminare

Materialien zum Aneignen des Lehrstoffes

Obligatorische Literatur

Vom Institut veröffentlichter Lehrstoff

Attila Almási, Zsuzsanna Rozmer, Pál Perjési: Pharmaceutical Chemistry I. Laboratory Experiments and Commentary, electronic educational material, PTE 2014.

Skript

Pharmaceutical Chemistry Practice I., Laboratory manual, University of Pécs, 2015.

Empfohlene Literatur

Voraussetzung zum Absolvieren des Semesters

Acknowledgement of the course is in accord with the Code of Studies and Examinations. Participation in the practices is obligatory. Maximum three absences can be accepted. Students have to write at least four short tests on the practices. The average of the results must be at least 50%. Quantitative measurements should be carried out with the acceptance level of 70%! The practical work (results of the written tests and the experimental work) is evaluated by a practice grade.

Semesteranforderungen

The short practical test can be made up on the next practical.

Möglichkeiten zur Nachholung der Fehlzeiten

There is no opportunity to make up missed practices.

Prüfungsfragen

Questions of the above short tests are from the topics of the practical and seminary.

Prüfer

Praktika, Seminarleiter/innen

  • Almási Attila
  • KURZUSHOZ RENDELT OKTATÓ
  • Mészáros Petra